多巴胺系统成像:聚焦药理学MRI与神经黑色素成像
本文综述了多巴胺系统成像的进展,重点介绍药理学MRI(phMRI)和神经黑色素敏感MRI(NM-MRI)两种技术。phMRI通过给予药理学刺激评估脑血流动力学变化,间接反映多巴胺功能;NM-MRI可活体显示并半定量黑质神经黑色素,作为长期多巴胺功能或神经元变性的替代指标。两者目前主要用于临床研究,但NM-MRI在帕金森病等多巴胺能神经退行性疾病中具有临床转化前景。
要点
- NM-MRI可活体半定量黑质神经黑色素,作为多巴胺能神经元变性的替代标志物。
- phMRI通过药理学刺激下的血流动力学反应间接评估多巴胺功能。
- 两者尚处临床研究阶段,NM-MRI在帕金森病等疾病中转化前景较好。
关键影像表现/征象
- NM-MRI可活体可视化并半定量黑质中的神经黑色素。
- 神经黑色素位于黑质纹状体通路多巴胺能神经元的胞体中。
- phMRI通过给予药理学刺激并评估其脑血流动力学效应来间接评估多巴胺功能。
诊断标准与关键数值
- NM-MRI以黑质神经黑色素信号作为长期多巴胺功能或多巴胺能神经元变性的替代指标。
- phMRI以药理学刺激下的脑血流动力学反应间接反映多巴胺功能。
临床应用与阅片要点
- NM-MRI可尝试用于帕金森病等多巴胺能神经退行性疾病的辅助评估。
- phMRI和NM-MRI目前主要用于临床研究,日常阅片报告需谨慎解读。
- MR方法相对PET/SPECT无辐射、成本较低、通常更无创且耗时更少。
局限性
- phMRI和NM-MRI目前仍主要用于临床研究,尚未广泛进入临床常规。
- 本文为综述,未报告系统检索策略与纳入文献数量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The dopamine system in the brain is involved in a variety of neurologic and psychiatric disorders, such as Parkinson's disease, attention-deficit/hyperactivity disorder and psychosis. Different aspects of the dopamine system can be visualized and measured with positron emission tomography (PET) and single photon emission computed tomography (SPECT), including dopamine receptors, dopamine transporters, and dopamine release. New developments in MR imaging also provide proxy measures of the dopamine system in the brain, offering alternatives with the advantages MR imaging, i.e. no radiation, lower costs, usually less invasive and time consuming. This review will give an overview of these developments with a focus on the most developed techniques: pharmacological MRI (phMRI) and neuromelanin sensitive MRI (NM-MRI). PhMRI is a collective term for functional MRI techniques that administer a pharmacological challenge to assess its effects on brain hemodynamics. By doing so, it indirectly assesses brain neurotransmitter function such as dopamine function. NM-MRI is an upcoming MRI technique that enables in vivo visualization and semi-quantification of neuromelanin in the substantia nigra. Neuromelanin is located in the cell bodies of dopaminergic neurons of the nigrostriatal pathway and can be used as a proxy measure for long term dopamine function or degeneration of dopaminergic neurons. Both techniques are still primarily used in clinical research, but there is promise for clinical application, in particular for NM-MRI in dopaminergic neurodegenerative diseases like Parkinson's disease.
引用
- Reneman L, van der Pluijm M, Schrantee A, et al. Imaging of the dopamine system with focus on pharmacological MRI and neuromelanin imaging. Eur J Radiol. 2021. PMID: 34004428. doi:10.1016/j.ejrad.2021.109752
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。